Koninklijke Philips Gross Profit 2010-2025 | PHG

Koninklijke Philips annual/quarterly gross profit history and growth rate from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Koninklijke Philips gross profit for the quarter ending March 31, 2025 was $1.948B, a 3.34% increase year-over-year.
  • Koninklijke Philips gross profit for the twelve months ending March 31, 2025 was $8.435B, a 6.78% increase year-over-year.
  • Koninklijke Philips annual gross profit for 2024 was $8.411B, a 4.34% increase from 2023.
  • Koninklijke Philips annual gross profit for 2023 was $8.061B, a 6.35% increase from 2022.
  • Koninklijke Philips annual gross profit for 2022 was $7.58B, a 10.62% decline from 2021.
Koninklijke Philips Annual Gross Profit
(Millions of US $)
2024 $8,411
2023 $8,061
2022 $7,580
2021 $8,480
2020 $10,031
2019 $9,940
2018 $10,101
2017 $9,246
2016 $11,743
2015 $10,944
2014 $10,908
2013 $12,869
2012 $12,101
2011 $12,044
2010 $12,677
2009 $11,267
Koninklijke Philips Quarterly Gross Profit
(Millions of US $)
2025-03-31 $1,948
2024-09-30 $2,206
2024-06-30 $2,142
2023-06-30 $2,139
2023-03-31 $1,885
2022-06-30 $1,843
2021-06-30 $2,156
2020-06-30 $2,016
2019-06-30 $2,389
2018-06-30 $2,392
2017-06-30 $2,118
2016-12-31 $3,472
2016-09-30 $2,904
2016-06-30 $2,867
2016-03-31 $2,500
2015-12-31 $3,101
2015-09-30 $2,695
2015-06-30 $2,760
2015-03-31 $2,388
2014-12-31 $2,730
2014-09-30 $2,422
2014-06-30 $2,991
2014-03-31 $2,766
2013-12-31 $3,906
2013-09-30 $3,122
2013-06-30 $3,065
2013-03-31 $2,775
2012-12-31 $3,851
2012-09-30 $3,265
2012-06-30 $2,509
2012-03-31 $2,783
2011-12-31 $2,950
2011-09-30 $2,735
2011-06-30 $2,940
2011-03-31 $3,301
2010-12-31 $3,754
2010-09-30 $3,011
2010-06-30 $2,911
2010-03-31 $3,019
2009-12-31 $5,210
2009-09-30 $2,898
2009-06-30 $1,586
2009-03-31 $2,148
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $23.611B $19.503B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.329B 28.06
Boston Scientific (BSX) United States $153.315B 38.38
Stryker (SYK) United States $149.550B 31.27
EssilorLuxottica (ESLOY) France $129.320B 0.00
Medtronic (MDT) Ireland $113.223B 16.05
Lonza Group Ag (LZAGY) Switzerland $50.710B 0.00
Haleon (HLN) United Kingdom $46.111B 26.31
ResMed (RMD) United States $37.519B 28.18
GE HealthCare Technologies (GEHC) United States $34.854B 16.55
Agilent Technologies (A) United States $34.275B 22.34
Terumo (TRUMY) Japan $25.791B 33.50
Insulet (PODD) United States $21.226B 83.32
Zimmer Biomet Holdings (ZBH) United States $18.499B 11.88
Baxter (BAX) United States $15.975B 11.93
Smith & Nephew SNATS (SNN) United Kingdom $13.209B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.821B 23.74
Lantheus Holdings (LNTH) United States $5.509B 13.90
Prestige Consumer Healthcare (PBH) United States $3.962B 17.70
Perrigo (PRGO) Ireland $3.748B 9.50
Haemonetics (HAE) United States $3.663B 16.68
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.419B 28.41
ICU Medical (ICUI) United States $3.352B 24.72
QuidelOrtho (QDEL) United States $2.041B 14.04
LeMaitre Vascular (LMAT) United States $1.894B 42.35
AtriCure (ATRC) United States $1.554B 0.00
Acuren (TIC) United States $1.375B 0.00
AdaptHealth (AHCO) United States $1.264B 12.84
Green Thumb Industries (GTBIF) United States $1.169B 26.29
Neogen (NEOG) United States $1.135B 14.53
Phibro Animal Health (PAHC) United States $1.133B 14.48
BioLife Solutions (BLFS) United States $1.081B 0.00
InMode (INMD) Israel $0.961B 9.69
Kestra Medical Technologies (KMTS) United States $0.783B 0.00
Owens & Minor (OMI) United States $0.718B 5.96
Maravai LifeSciences Holdings (MRVI) United States $0.675B 0.00
CeriBell (CBLL) United States $0.673B 0.00
Evolus (EOLS) United States $0.594B 0.00
Curaleaf Holdings (CURLF) Canada $0.551B 0.00
Valneva SE (VALN) France $0.494B 0.00
Tilray Brands (TLRY) Canada $0.488B 0.00
Capricor Therapeutics (CAPR) United States $0.458B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
Quanterix (QTRX) United States $0.346B 0.00
SNDL (SNDL) Canada $0.328B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Cerus (CERS) United States $0.298B 0.00
Viemed Healthcare (VMD) United States $0.280B 23.60
ZimVie (ZIMV) United States $0.279B 12.67
Sanuwave Health (SNWV) United States $0.271B 0.00
Sanara MedTech (SMTI) United States $0.266B 0.00
Aurora Cannabis (ACB) Canada $0.251B 74.50
Cresco Labs (CRLBF) United States $0.251B 0.00
Brainsway (BWAY) Israel $0.242B 64.00
Biote (BTMD) United States $0.229B 6.45
OraSure Technologies (OSUR) United States $0.229B 0.00
Canopy Growth (CGC) Canada $0.219B 0.00
High Tide (HITI) Canada $0.190B 0.00
Utah Medical Products (UTMD) United States $0.187B 15.21
TriSalus Life Sciences (TLSI) United States $0.185B 0.00
Organigram Global (OGI) Canada $0.185B 0.00
Verano Holdings (VRNOF) United States $0.182B 0.00
Omeros (OMER) United States $0.181B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.128B 15.73
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.096B 12.33
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
MacroGenics (MGNX) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.086B 0.00
Veru (VERU) United States $0.086B 0.00
Zynex (ZYXI) United States $0.081B 0.00
Apyx Medical (APYX) United States $0.081B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Agape ATP (ATPC) $0.069B 0.00
InterCure (INCR) Israel $0.067B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
Jushi Holdings (JUSHF) United States $0.060B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Nephros (NEPH) United States $0.042B 56.86
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.81
Safety Shot (SHOT) United States $0.030B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Senestech (SNES) United States $0.011B 0.00
IM Cannabis (IMCC) Canada $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00